尋找研究成果

在所有內容中搜尋

為 研究成果 進行篩選

搜尋概念
已選取的篩選器

出版年份

  • 2020
  • 2019
  • 2018
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

作者

  • Wu-Chou Su
2011
13 引文 斯高帕斯(Scopus)
2016

Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer

Scagliotti, G., Kang, J. H., Smith, D., Rosenberg, R., Park, K., Kim, S. W., Su, W. C., Boyd, T. E., Richards, D. A., Novello, S., Hynes, S. M., Myrand, S. P., Lin, J., Smyth, E. N., Wijayawardana, S., Lin, A. B. & Pinder-Schenck, M., 2016 十月 1, 於 : Investigational New Drugs. 34, 5, p. 625-635 11 p.

研究成果: Article

26 引文 斯高帕斯(Scopus)
2019
開啟存取
2016

A randomized phase 2 study comparing the combination of ficlatuzumab and gefitinib with gefitinib alone in asian patients with advanced stage pulmonary adenocarcinoma

Mok, T. S. K., Geater, S. L., Su, W. C., Tan, E. H., Yang, J. C. H., Chang, G. C., Han, M., Komarnitsky, P., Payumo, F., Garrus, J. E., Close, S. & Park, K., 2016, 於 : Journal of Thoracic Oncology. 11, 10, p. 1736-1744 9 p.

研究成果: Article

23 引文 斯高帕斯(Scopus)
2014
9 引文 斯高帕斯(Scopus)
2015

An increase in glucosylceramide synthase induces BclxL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells

Chiu, W. H., Su, W. C., Li, C. L., Chen, C. L. & Lin, C. F., 2015 一月 1, 於 : Oncotarget. 6, 24, p. 20513-20524 12 p.

研究成果: Article

6 引文 斯高帕斯(Scopus)
2019
開啟存取
2016

Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer

Jen, J., Lin, L. L., Chen, H. T., Liao, S. Y., Lo, F. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2016 五月 5, 於 : Oncogene. 35, 18, p. 2357-2369 13 p.

研究成果: Article

23 引文 斯高帕斯(Scopus)
2011

Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells

Chen, Y. J., Huang, W. C., Wei, Y. L., Hsu, S. C., Yuan, P., Lin, H. Y., Wistuba, I. I., Lee, J. J., Yen, C. J., Su, W. C., Chang, K. Y., Chang, W. C., Chou, T. C., Chou, C. K., Tsai, C. H. & Hung, M. C., 2011 六月 29, 於 : PloS one. 6, 6, e21428.

研究成果: Article

60 引文 斯高帕斯(Scopus)
2016

Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy

Wang, Y-C., Wang, S. A., Chen, P. H., Hsu, T. I., Yang, W. B., Chuang, Y. P., Su, W-C., Liaw, H-J., Chang, W. C. & Hung, J-J., 2016 七月 14, 於 : Oncogene. 35, 28, p. 3669-3680 12 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)
2012

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase 2b/3 randomised trial

Miller, V. A., Hirsh, V., Cadranel, J., Chen, Y. M., Park, K., Kim, S. W., Zhou, C., Su, W. C., Wang, M., Sun, Y., Heo, D. S., Crino, L., Tan, E. H., Chao, T. Y., Shahidi, M., Cong, X. J., Lorence, R. M. & Yang, J. C. H., 2012 五月 1, 於 : The Lancet Oncology. 13, 5, p. 528-538 11 p.

研究成果: Article

720 引文 斯高帕斯(Scopus)
2018
4 引文 斯高帕斯(Scopus)
2019

Erratum: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy (Oncotarget (2015) 6 (13671–13687) DOI: 10.18632/oncotarget.3701)

Hsu, T. I., Chen, Y. J., Hung, C. Y., Wang, Y. C., Lin, S. J., Su, W. C., Lai, M. D., Kim, S. Y., Wang, Q., Qian, K., Goto, M., Zhao, Y., Kashiwada, Y., Lee, K. H., Chang, W. C. & Hung, J. J., 2019 一月 1, 於 : Oncotarget. 10, 60, p. 6536-6537 2 p.

研究成果: Comment/debate

2015

Epidermal growth factor receptor tyrosine Kinase inhibitor treatment response in advanced lung adenocarcinomas with G719X/L861Q/S768I mutations

Chiu, C. H., Yang, C. T., Shih, J. Y., Huang, M. S., Su, W. C., Lai, R. S., Wang, C. C., Hsiao, S. H., Lin, Y. C., Ho, C. L., Hsia, T. C., Wu, M. F., Lai, C. L., Lee, K. Y., Lin, C. B., Yu-Wung Yeh, D., Chuang, C. Y., Chang, F. K., Tsai, C. M., Perng, R. P. 及其他1, Chih-Hsin Yang, J., 2015 五月 30, 於 : Journal of Thoracic Oncology. 10, 5, p. 793-799 7 p.

研究成果: Article

101 引文 斯高帕斯(Scopus)
2016

Elucidating Quantum Confinement in Graphene Oxide Dots Based on Excitation-Wavelength-Independent Photoluminescence

Yeh, T. F., Huang, W. L., Chung, C. J., Chiang, I. T., Chen, L. C., Chang, H. Y., Su, W. C., Cheng, C., Chen, S. J. & Teng, H., 2016 六月 2, 於 : Journal of Physical Chemistry Letters. 7, 11, p. 2087-2092 6 p.

研究成果: Article

73 引文 斯高帕斯(Scopus)
2012

Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells

Chiu, W. H., Luo, S. J., Chen, C. L., Cheng, J. H., Hsieh, C. Y., Wang, C. Y., Huang, W. C., Su, W. C. & Lin, C. F., 2012 五月 1, 於 : Biochemical Pharmacology. 83, 9, p. 1159-1171 13 p.

研究成果: Article

68 引文 斯高帕斯(Scopus)
2015

Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)

Hosgood, H. D., Song, M., Hsiung, C. A., Yin, Z., Shu, X. O., Wang, Z., Chatterjee, N., Zheng, W., Caporaso, N., Burdette, L., Yeager, M., Berndt, S. I., Landi, M. T., Chen, C. J., Chang, G. C., Hsiao, C. F., Tsai, Y. H., Chien, L. H., Chen, K. Y., Huang, M. S. 及其他46, Su, W. C., Chen, Y. M., Chen, C. H., Yang, T. Y., Wang, C. L., Hung, J. Y., Lin, C. C., Perng, R. P., Chen, C. Y., Chen, K. C., Li, Y. J., Yu, C. J., Chen, Y. S., Chen, Y. H., Tsai, F. Y., Kim, C., Seow, W. J., Bassig, B. A., Wu, W., Guan, P., He, Q., Gao, Y. T., Cai, Q., Chow, W. H., Xiang, Y. B., Lin, D., Wu, C., Wu, Y. L., Shin, M. H., Hong, Y. C., Matsuo, K., Chen, K., Wong, M. P., Lu, D., Jin, L., Wang, J. C., Seow, A., Wu, T., Shen, H., Fraumeni, J. F., Yang, P. C., Chang, I. S., Zhou, B., Chanock, S. J., Rothman, N. & Lan, Q., 2015 二月 6, 於 : Human genetics. 134, 3, p. 333-341 9 p.

研究成果: Article

23 引文 斯高帕斯(Scopus)
2020

Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model

Chien, L. H., Chen, C. H., Chen, T. Y., Chang, G. C., Tsai, Y. H., Hsiao, C. F., Chen, K. Y., Su, W. C., Wang, W. C., Huang, M. S., Chen, Y. M., Chen, C. Y., Liang, S. K., Chen, C. Y., Wang, C. L., Lee, M. H., Chung, R. H., Tsai, F. Y., Hu, J. W., Katki, H. A. 及其他8, Chatterjee, N., Chanock, S. J., Rothman, N., Lan, Q., Yang, P. C., Chen, C. J., Chang, I. S. & Hsiung, C. A., 2020 二月 1, 於 : Cancer Epidemiology Biomarkers and Prevention. 29, 2, p. 452-459 8 p.

研究成果: Article

開啟存取
2015

AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer

Jänne, P. A., Chih-Hsin Yang, J., Kim, D. W., Planchard, D., Ohe, Y., Ramalingam, S. S., Ahn, M. J., Kim, S. W., Su, W. C., Horn, L., Haggstrom, D., Felip, E., Kim, J. H., Frewer, P., Cantarini, M., Brown, K. H., Dickinson, P. A., Ghiorghiu, S. & Ranson, M., 2015 四月 30, 於 : New England Journal of Medicine. 372, 18, p. 1689-1699 11 p.

研究成果: Article

1228 引文 斯高帕斯(Scopus)
2018

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

Gerber, D. E., Horn, L., Boyer, M., Sanborn, R., Natale, R., Palmero, R., Bidoli, P., Bondarenko, I., Germonpre, P., Ghizdavescu, D., Kotsakis, A., Lena, H., Losonczy, G., Park, K., Su, W. C., Tang, M., Lai, J., Kallinteris, N. L., Shan, J. S., Reck, M. 及其他1, Spigel, D. R., 2018 七月 1, 於 : Annals of Oncology. 29, 7, p. 1548-1553 6 p.

研究成果: Article

7 引文 斯高帕斯(Scopus)
2013

Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers

Wu, X., Wang, L., Ye, Y., Aakre, J. A., Pu, X., Chang, G. C., Yang, P. C., Roth, J. A., Marks, R. S., Lippman, S. M., Chang, J. Y., Lu, C., Deschamps, C., Su, W. C., Wang, W. C., Huang, M. S., Chang, D. W., Li, Y., Pankratz, V. S., Minna, J. D. 及其他4, Hong, W. K., Hildebrandt, M. A. T., Hsiung, C. A. & Yang, P., 2013 七月 1, 於 : Cancer Research. 73, 13, p. 4028-4038 11 p.

研究成果: Article

36 引文 斯高帕斯(Scopus)
2018
9 引文 斯高帕斯(Scopus)

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer

Wu, Y. L., Zhang, L., Kim, D. W., Liu, X., Lee, D. H., Yang, J. C. H., Ahn, M. J., Vansteenkiste, J. F., Su, W. C., Felip, E., Chia, V., Glaser, S., Pultar, P., Zhao, S., Peng, B., Akimov, M. & Tan, D. S. W., 2018 十一月 1, 於 : Journal of Clinical Oncology. 36, 31, p. 3101-3109 9 p.

研究成果: Article

50 引文 斯高帕斯(Scopus)
7 引文 斯高帕斯(Scopus)
4 引文 斯高帕斯(Scopus)

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

John, T., Akamatsu, H., Delmonte, A., Su, W. C., Lee, J. S., Chang, G. C., Huang, X., Jenkins, S. & Wu, Y. L., 2018 十二月, 於 : Lung Cancer. 126, p. 133-138 6 p.

研究成果: Article

6 引文 斯高帕斯(Scopus)
4 引文 斯高帕斯(Scopus)
2019

Tissue and plasma EGFR mutation analysis in the FLAURA trial: Osimertinib versus Comparator EGFR tyrosine kinase inhibitor as first-line treatment in patients with EGFR-mutated advanced non–small cell lung cancer

Gray, J. E., Okamoto, I., Sriuranpong, V., Vansteenkiste, J., Imamura, F., Lee, J. S., Pang, Y. K., Cobo, M., Kasahara, K., Cheng, Y., Nogami, N., Cho, E. K., Su, W. C., Zhang, G., Huang, X., Li-Sucholeiki, X., Lentrichia, B., Dearden, S., Jenkins, S., Saggese, M. 及其他2, Rukazenkov, Y. & Ramalingam, S. S., 2019 十一月 15, 於 : Clinical Cancer Research. 25, 22, p. 6644-6652 9 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)
2020

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

Sequist, L. V., Han, J. Y., Ahn, M. J., Cho, B. C., Yu, H., Kim, S. W., Yang, J. C. H., Lee, J. S., Su, W. C., Kowalski, D., Orlov, S., Cantarini, M., Verheijen, R. B., Mellemgaard, A., Ottesen, L., Frewer, P., Ou, X. & Oxnard, G., 2020 三月, 於 : The Lancet Oncology. 21, 3, p. 373-386 14 p.

研究成果: Article

10 引文 斯高帕斯(Scopus)